The effect of the cardiac myosin activator, omecamtiv mecarbil, on right ventricular structure and function in chronic systolic heart failure (COSMIC-HF)

Sørensen, T. B. et al. (2021) The effect of the cardiac myosin activator, omecamtiv mecarbil, on right ventricular structure and function in chronic systolic heart failure (COSMIC-HF). European Journal of Heart Failure, 23(6), pp. 1052-1056. (doi: 10.1002/ejhf.2181) (PMID:33826209)

Full text not currently available from Enlighten.

Abstract

No abstract available.

Item Type:Articles (Letter)
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:McMurray, Professor John
Authors: Sørensen, T. B., Minamisawa, M., Liu, J., Claggett, B., Papolos, A. I., Felker, G. M., McMurray, J. J.V., Legg, J. C., Malik, F. I., Honarpour, N., Kurtz, C. E., Teerlink, J. R., and Solomon, S. D.
College/School:College of Medical Veterinary and Life Sciences > School of Cardiovascular & Metabolic Health
Journal Name:European Journal of Heart Failure
Publisher:Wiley
ISSN:1388-9842
ISSN (Online):1879-0844
Published Online:07 April 2021

University Staff: Request a correction | Enlighten Editors: Update this record